EICHORCondition: Pancreas Adenocarcinoma · Sponsor: NovoCure Ltd.
Brief Summary: The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFields) in combination with gemcitabine and nab-paclitaxel, for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Grandview Medical Center, Cancer Center | Birmingham, Alabama, United States | — |
| Infirmary Cancer Care | Mobile, Alabama, United States | — |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Arizona Oncology Associates, PC- HOPE - US Oncology Research | Tucson, Arizona, United States | — |
| University of Arizona Cancer Center | Tucson, Arizona, United States | — |
| Pacific Cancer Medical Center | Anaheim, California, United States | — |
| Providence Medical Foundation | Fullerton, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| Dignity Health - Mercy Cancer Centers | Sacramento, California, United States | — |
| Sutter Cancer Center Sacramento | Sacramento, California, United States | — |
| Ridley-Tree Cancer Center | Santa Barbara, California, United States | — |
| Adventist Health St. Helena - Martin-O'Neil Cancer Center (MOCC) | St. Helena, California, United States | — |
+ 187 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03377491